In addition to NPC, SSTR2 is expressed in other malignancies, including neuroendocrine tumor, thyroid carcinoma, breast cancer, and meningioma, expanding its potential applications in tumor theranostics (12–14). This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.